0001415889-25-024448.txt : 20250912 0001415889-25-024448.hdr.sgml : 20250912 20250912182517 ACCESSION NUMBER: 0001415889-25-024448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250910 FILED AS OF DATE: 20250912 DATE AS OF CHANGE: 20250912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRENSKY ZACHARY CENTRAL INDEX KEY: 0001167585 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42831 FILM NUMBER: 251312697 MAIL ADDRESS: STREET 1: C/O LB PHARMACEUTICALS INC CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LB PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001691082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 575 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 917-450-6581 MAIL ADDRESS: STREET 1: 575 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: LB PHARMACEUTICALS INC. DATE OF NAME CHANGE: 20161129 4 1 form4-09122025_060911.xml X0508 4 2025-09-10 0001691082 LB PHARMACEUTICALS INC LBRX 0001167585 PRENSKY ZACHARY C/O LB PHARMACEUTICALS INC ONE PENNSYLVANIA PLAZA, SUITE 1025 NEW YORK NY 10119 true false false false 0 Stock Option (Right to Buy) 64.15 2025-09-10 4 D 0 3944 D 2028-11-13 Common Stock 3944 0 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 3944 A 2028-11-13 Common Stock 3944 3944 D Stock Option (Right to Buy) 69.72 2025-09-10 4 D 0 896 D 2029-12-22 Common Stock 896 0 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 896 A 2029-12-22 Common Stock 896 896 D Stock Option (Right to Buy) 69.72 2025-09-10 4 D 0 1255 D 2030-08-30 Common Stock 1255 0 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 1255 A 2030-08-30 Common Stock 1255 1255 D Stock Option (Right to Buy) 41.84 2025-09-10 4 D 0 17929 D 2033-08-24 Common Stock 17929 0 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 17929 A 2033-08-24 Common Stock 17929 17929 D Stock Option (Right to Buy) 41.84 2025-09-10 4 D 0 53787 D 2034-06-26 Common Stock 53787 0 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 53787 A 2034-06-26 Common Stock 53787 53787 D Stock Option (Right to Buy) 15 2025-09-10 4 A 0 22449 0 A 2035-09-09 Common Stock 22449 22449 D Immediately exercisable. The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect. One fourth (1/4) of the shares subject to the option award vested on August 25, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. One fourth (1/4) of the shares subject to the option award vested on June 28, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date. /s/ Marc Panoff, Attorney-in-Fact 2025-09-12